Quantcast

Latest keratitis Stories

2009-09-16 08:00:00

TAMPA, Fla., Sept. 16 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007. (Logo: http://www.newscom.com/cgi-bin/prnh/20080220/CLW064LOGO )...

2009-07-21 14:48:54

A new study suggests that some contact lens solutions do not properly disinfect against Acanthamoeba, a free-living organism in the environment that can cause a painful vision-threatening infection. The researchers from the Centers for Disease Control and Prevention, Public Health Service, and the U.S. Department of Health and Human Services, Atlanta, Georgia, report their findings in the July 2009 issue of the Journal of Clinical Microbiology.Acanthamoeba are found in a variety of...

2009-06-22 12:06:00

WASHINGTON, June 22 /PRNewswire-FirstCall/ -- The Washington, D.C.-based law firm of Schmidt & Clark, LLP, is announcing the results of an inspection conducted by the U.S. Food and Drug Administration where investigators determined that a subsidiary of Abbott Park, Ill.-based Abbott Laboratories Inc. (NYSE: ABT) failed to disclose multiple reports of a serious parasitic eye infection for more than a year. In an Associated Press story reported June 20, 2009, Schmidt & Clark Managing...

88429946b57277552c51713e879606f0
2009-06-01 07:20:00

When contact lens maker Bausch & Lomb Inc. went private in 2007, it was not without good cause. Company leaders have explained that the company wanted to handle a disastrous recall of its popular lens cleaner "without a lot of outside distraction." In the past year, the optical products company has managed to quietly settle almost 600 lawsuits involving claims of fungal-infections, while dozens of individual claims are still waiting to be heard. In all, Bausch & Lomb Inc. has doled...

2009-04-10 12:36:00

New Contact Lens and Case Timer Solves Widespread Problem ST. LOUIS, April 10 /PRNewswire/ -- There are over 38 million contact lens wearers in the U.S. and children are the fastest growing segment. The contact lens industry is enjoying great success, but there is danger growing under those lenses. Danger in the form of hard to pronounce words like fusarium keratitis and acanthamoeba keratitis. These are nasty words that are causing eye health complications from minor eye infections to...

2009-01-26 14:44:00

Optometrists and other experts sponsor workshop to investigate increase in Acanthamoeba keratitis and to develop new testing methods to improve contact lens care products and protect against infections ST. LOUIS, Jan. 26 /PRNewswire/ -- In an effort to increase the safety and effectiveness of contact lenses and lens care products for consumers, doctors of optometry from the American Optometric Association (AOA) co-sponsored a workshop last week with the U.S. Food and Drug Administration's...

2009-01-26 10:02:00

TAMPA, Fla., Jan. 26 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, today announced that its New Drug Application (NDA) for ganciclovir ophthalmic gel, 0.15%, has been accepted for review by the U.S. Food and Drug Administration (FDA). Sirion Therapeutics is seeking approval for ganciclovir as a treatment for herpetic keratitis, an ocular disease caused by the herpes simplex virus. The FDA has issued an action date in late fall of...

2008-11-03 12:00:26

TAMPA, Fla., Nov. 3 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that studies of two investigational drugs in development for treatment of potentially blinding eye diseases will be presented at upcoming ophthalmology meetings: At the American Uveitis Society's annual invitational meeting (November 9, Atlanta Marriott Marquis, Atlanta), preliminary results will be presented from an anterior uveitis trial that...

2008-07-28 09:01:47

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), said that the internationally renowned Japanese ophthalmologist and corneal researcher, Kazuo Tsubota, MD, PhD, has agreed to join the Company's Scientific Advisory Board. Dr. Tsubota is currently Professor and Chairman of the Department of Ophthalmology at Keio University School of Medicine in Tokyo, Japan. "I have already had licensing discussions with Japanese pharmaceutical companies regarding EkcCide(TM)," said Dr. Tsubota, adding,...

2007-06-28 09:00:32

Bausch & Lomb today introduced its Ocuvite DF eye vitamin supplement, specifically developed for diabetics to help maintain eye health, at the American Optometric Association's (AOA) 110th Annual Congress. Diabetics face high blood sugar levels that can increase free radicals in the body. The oxidative stress associated with free radicals can in turn play a role in damaging the blood vessels of the eye's retina, a condition called diabetic retinopathy. This condition is the most...


Latest keratitis Reference Libraries

Onchocerca volvulus
2014-01-12 00:00:00

Onchocerca volvulus is a species of roundworm that is classified within the Nematoda phylum. This species causes the disease onchocerciasis, more commonly known as river blindness. The life cycle of this species is dependent upon an intermediate host, typically the black fly, and a definitive host, which is always a human. Its lifecycle begins when a black fly ingests microfilariae from a human host by consuming blood. The microfilariae that were present in the skin of the human host now...

More Articles (1 articles) »
Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related